Skip to content

Clinical trials

Phase 4 Autistic Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 4 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20092
20101
20113
20131
20143
20171
20192
20201
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status4
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Massachusetts General Hospital2
Montefiore Medical Center2
Daniel Coury1
Drexel University1
Eli Lilly and Company1
Federal University of São Paulo1
Gagan Joshi1
Isaac Melamed1
Medical University of South Carolina1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder22
Autism Spectrum Disorder9
Attention Deficit Disorder with Hyperactivity6
Asperger Syndrome4
Child Development Disorders, Pervasive3
Anxiety Disorders1
Bipolar Disorder1
Learning Disabilities1
Schizophrenia1
Spasm1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.